Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in Jinxin Reproductive Medicine (01951.HK) by 3.67 million shares on January 7, with a total net reduction of 7.017 million shares over the last five trading days [1] - Over the past 20 trading days, southbound funds have reduced their holdings on 14 days, resulting in a cumulative net reduction of 29.177 million shares [1] - As of now, southbound funds hold 1.456 billion shares of Jinxin Reproductive Medicine, accounting for 52.78% of the company's total issued ordinary shares [1] Group 2 - Jinxin Reproductive Medicine Group Limited is an investment holding company primarily providing in vitro fertilization (IVF) services [1] - The company offers a range of services through its subsidiaries, including assisted reproductive services, management services, mobile surgical center facility services, auxiliary medical services, obstetrics and pediatrics medical services, as well as the sale of medical consumables and equipment [1] - The company primarily operates in China and the United States [1]
锦欣生殖（01951.HK）：1月7日南向资金减持367.45万股